Structure via PubChem · Public domain (PubChem)
triheptanoin
Sign in to saveTriheptanoin, sold under the brand name Dojolvi, is a medication for the treatment of children and adults with molecularly confirmed long-chain fatty acid oxidation disorders (LC-FAOD).
Key facts
- Drug.image
- Triheptanoin.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 200
- Drug.alt
- Skeletal formula of triheptanoin
- Drug.image2
- Triheptanoin 3D spacefill.png
- Drug.image_class2
- bg-transparent
- Drug.width2
- 240
- Drug.alt2
- Space-filling model of the triheptanoin molecule
- Drug.tradename
- Dojolvi
- Drug.DailyMedID
- Triheptanoin
- Drug.routes_of_administration
- By mouth
- Drug.class
- Glycerolipids
- Drug.ATC_prefix
- A16
- Drug.ATC_suffix
- AX17
- Drug.legal_CA
- Rx-only
- Drug.legal_US
- Rx-only
- Drug.CAS_number
- 620-67-7
- Drug.PubChem
- 69286
via Wikipedia infobox
Chemical data
- Formula
- C24H44O6
- Molecular weight
- 428.6 g/mol
- IUPAC name
- 2,3-di(heptanoyloxy)propyl heptanoate
- SMILES
- CCCCCCC(=O)OCC(COC(=O)CCCCCC)OC(=O)CCCCCC
- InChIKey
- PJHKBYALYHRYSK-UHFFFAOYSA-N
- XLogP
- 7.3
- Polar surface area
- 78.9 Ų
- H-bond donors
- 0
- H-bond acceptors
- 6
- Formal charge
- 0
via PubChem
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 428.314
Show 3 more facts
- chemical formula
- C₂₄H₄₄O₆
- canonical SMILES
- CCCCCCC(=O)OCC(COC(=O)CCCCCC)OC(=O)CCCCCC
- Commons category
- Triheptanoin
Sources (2)
via Wikidata · CC0
~3 min read
Encyclopedic overview
7 sectionsContents
- Medical uses
- History
- Names
- See also
- References
- Further reading
- External links
Triheptanoin, sold under the brand name Dojolvi, is a medication for the treatment of children and adults with molecularly confirmed long-chain fatty acid oxidation disorders (LC-FAOD).
The most common adverse reactions include abdominal pain, diarrhea, vomiting, and nausea.
Excerpted from Wikipedia’s “triheptanoin” article, available under the CC BY-SA 4.0 licence.